Hernan Inojosa

MD | Future neurologist | interested in understanding MS with Data | 2x latino (venezuelan and brazilian) living in Germany.

[JAMA @JAMA_current]

Viewpoint from @StanfordMed and @StanfordHealth authors examines recent evidence on the gender pay gap in US medical professions and its relationship with motherhood (the “motherhood penalty”) and suggests opportunities for mitigating inequity. https://t.co/s6BkhoveKw

[MSJ @MSJ_Research]

Use of techniques derived from generative artificial intelligence, specifically large language models, hold potentials across the continuum of #MultipleSclerosis management.

Review from @HernanInojosa @TZiemssen @tudresden_de ▶️ https://t.co/JPbn6Ft8uH

[Hernan Inojosa @HernanInojosa]

Sad story in so many aspects.

[Fascinating @fasc1nate]

In September 1986, a German climber set out for a hike in the Swiss Alps — and was never seen again. Nearly 40 years later, melting glaciers revealed his remains and hiking gear. And this is not a unique discovery.

Studies show that glaciers in Switzerland lost half their volume between 1931 and 2016 and another 12 percent between 2016 and 2021.

Recently, this rapid melting has exposed the remains of several of the 300 or so hikers who went missing in the Alps in the last century.

[Hernan Inojosa @HernanInojosa]

With the current announcement of Gemini by @GoogleAI, I asked a first question, a very simple one... and it failed miserably.
Recommendation of Natalizumab or Fingolimod to a patient after a #CIS in Germany? That is beyond hit hard and early...😴

[Hernan Inojosa @HernanInojosa]

Today, I had a record of 7 meetings. I'm exhausted but happy for promising collaborations... Insightful time with the team of @ms_sherpa, LLM group of @EKFZdigital, an initiation visit of a phase III study (with paediatric MS!) and with the chiefs #Akguen and @TZiemssen

[Zach London @zach_london]

🧠 Looking for a comprehensive, yet accessible educational resource for residency training in #NeuroOphthalmology?

The curtains part, revealing...

"Neuro-Ophthalmology At Your Fingertips," a free online resource by Dr. Jonathan Trobe @UMneurosciences
https://t.co/S1F48MBlU6

[Hernan Inojosa @HernanInojosa]

Insightful weekend at the advent symposium of the MS centrer at the @tudresden_de. Looking forward to changes in medicine in 2050. Hopefully, we can stop #PIRA or whatever we call disease progression that year.

[Bundesministerium für Wirtschaft und Energie @BMWE_]

Der Terrorangriff der Hamas auf #Israel ist jetzt bald vier Wochen her. Vieles ist seitdem passiert, die öffentliche Debatte aufgeheizt und verworren. Im Video deshalb einige Gedanken von Vizekanzler und Minister Robert #Habeck zur Einordnung und Differenzierung.

[Jakob Nikolas Kather @jnkath]

Just out in @NatureMedicine. A simple message, but very relevant: we should use #LLMs for their logical reasoning skills, not as knowledge databases. With @DanielTruhn and Jorge Reis-Filho 🌟🌟
@EKFZdigital @DKFZ @NCT_UCC_DD @NCT_HD @Medizin_TUD @tudresden_de

[Hernan Inojosa @HernanInojosa]

First day at @ECTRIMS #MSMilan2023 with the best company. My highlights were the treatment strategies for elderly, #PIRA and the AI session. No field is evolving this fast! 🧠🔥

[Nat Rev Neurology @NatRevNeurol]

Ongoing Challenges in the Diagnosis of MOGAD https://t.co/GfBUDy5sdz

[Hernan Inojosa @HernanInojosa]

@ChiaraPinarello @TZiemssen Bravíssma, Chiara. You've earned this!

[Chiara Pinarello @ChiaraPinarello]

Here it is, the best Review on the digital assessment and management of MS fatigue you can read today, sipping a good coffee. Enjoy our work! @HernanInojosa @TZiemssen

https://t.co/ah0l1tmA4N

[ECTRIMS @ECTRIMS]

💊 The International Advisory Committee on Clinical Trials in #MS has published 5 new articles aimed at helping #MSResearchers improve the quality of their studies. Read more here: https://t.co/caMo1JpXtp #ClinicalTrials @mssociety

[Hernan Inojosa @HernanInojosa]

I'd like to share our brief communication regarding the use of LLMs (e.g. #ChatGPT) in communication with other physicians/pwMS #MS. With proper regulation and safety measures, communication in medicine will change!
https://t.co/rtxkdnmGYq
@TZiemssen @jnkath @Stephen44026116

[Dr. Brandon Beaber @Brandon_Beaber]

If you have resolved hepatitis B and take b-cell depleting drugs such as rituximab or ocrevus, do you need to take antivirals? Maybe not. This case series (28 people) showed no hepatitis B reactivation even without antivirals. Author: @XMontalban https://t.co/W3zKc7cB6w

[Else Kröner Fresenius Center for Digital Health @EKFZdigital]

Join the next #EKFZLecture with @VasilKostin on SEP 13 | 4pm. The MD Student at Prague Unversity and co-founder of Wrest will show his personal pathway on building a #startup that got to Forbes 30 under 30 Czechia ➡️https://t.co/4HjzcImyuu @Stephen44026116

[Hernan Inojosa @HernanInojosa]

Very insightful, motivating and instructive day at the @tudresden_de and the "Medizindidaktik Workshop". Some slides of science meeting education:

[Dr. Brandon Beaber @Brandon_Beaber]

Do you need contrast? ESMRMB-GREC and ESNR Multiple Sclerosis Working Group:"The use of [gadolinium] is generally recommended in the diagnostic workup in subjects with suspected MS and is generally not necessary for routine monitoring in clinical practice" https://t.co/zCTYs3FZMY

[Jakob Nikolas Kather @jnkath]

Happy to have received an @ERC_Research 🇪🇺 starting grant of 1.5 M💶 to fund our research on #AI in #cancer 🤖🔬🏥. We are hiring on student / postgraduate / post doc level, reach out via https://t.co/K8ehns1Wup
@tudresden_de @EKFZdigital @NCT_HD @NCT_UCC_DD @Medizin_TUD @DKFZ